Data / Form D filings / TOSK INC
TOSK INC: Form D filings
TOSK INC, a pharmaceuticals company in Mountain View, CA, filed 9 Form D notices with the SEC between 2011 and 2022. The latest, on September 16, 2022, reports $100,000 sold of a $3 million offering to 1 investor.
Find out what TOSK INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2672 Bayshore Parkway, # 507, Mountain View, CA, 94043
- Phone
- (408) 245-6838
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Not Applicable
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1098412
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 16, 2022 | New notice | $3,000,000 | $100,000 | $2,900,000 | 1 | Sep 15, 2022 | sec.gov |
| Oct 29, 2019 | Amendment | $5,100,000 | $3,091,524 | $2,008,476 | 56 | Mar 23, 2016 | sec.gov |
| Jul 2, 2018 | Amendment | $5,100,000 | $1,518,802 | $3,581,198 | 31 | Mar 23, 2016 | sec.gov |
| May 26, 2017 | Amendment | $5,100,000 | $766,006 | $4,333,994 | 18 | Mar 23, 2016 | sec.gov |
| Mar 28, 2016 | New notice | $5,100,000 | $18,000 | $5,082,000 | 1 | Mar 23, 2016 | sec.gov |
| Aug 25, 2014 | Amendment | $5,449,274 | $5,449,274 | $0 | 74 | Dec 16, 2011 | sec.gov |
| May 13, 2013 | Amendment | $5,100,000 | $1,651,590 | $3,448,410 | 12 | Dec 16, 2011 | sec.gov |
| Mar 4, 2013 | Amendment | $5,100,000 | $1,311,588 | $3,788,412 | 10 | Dec 16, 2011 | sec.gov |
| Dec 23, 2011 | New notice | $5,100,000 | $798,000 | $4,302,000 | 1 | Dec 16, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brian Frenzel | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Sep 12, 2022 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TOSK INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.